학술논문

Gene-Replacement Therapy (GRT) in Spinal Muscular Atrophy Type 1 (SMA1): Long-Term Follow-Up From the Onasemnogene Abeparvovec Phase 1/2 Clinical Trial.
Document Type
Article
Source
Neuropediatrics. 2019 Supplement2, Vol. 50, pS1-S55. 55p.
Subject
*SPINAL muscular atrophy
*CLINICAL trials
Language
ISSN
0174-304X